Target audiences (Who is using the tool?) |
|
|
Format (How is information presented?) |
Infographic (eg, 1000-person diagram)† Frequently asked questions Peer-reviewed publication of a clinical practice guideline
|
|
Content (What information is presented?) |
Health outcomes of clinical interventions Benefits and harms Clinical risk scores Best practices for the topic Guideline recommendations
|
Decision under consideration is explicitly stated Information on test or intervention Benefits and harms Prompt to consider values and preferences Clinical risk scores
|
Passive dissemination (Examples of 1-way distribution of information to patients or physicians; no dialogue) |
Review articles such as the following: CTFPHC. Recommendations on screening for developmental delay. CMAJ 2016;188(8):579–87. Read the CTFPHC 1000-person handout that was distributed at a conference (eg, the Prostate Cancer—1000-Person Tool in Figure 1)4
|
|
Active implementation (Examples of 2-way exchange of information between patients and physicians; active dialogue) |
|
|